Growth hormone/insulin-like growth factor-I axis in obstructive sleep apnea syndrome: An update

Journal of Endocrinological Investigation

Volumn 33, Issue 3, 2010, Pages 192-196

  Lanfranco, F ^a   Motta, G ^a   Minetto, M A ^a   Ghigo, E ^a   Maccario, M ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

GH; IGF I; Obesity; OSAS; Sleep apnea syndrome

Indexed keywords

SOMATOMEDIN C;

CARDIOVASCULAR RISK; DISEASE ASSOCIATION; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE SENSITIVITY; HUMAN; HYPOXIA; MORBIDITY; MORTALITY; OBESITY; SHORT SURVEY; SLEEP APNEA SYNDROME; SLEEP DISORDER;

EID: 77952846023     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346580     Document Type: Short Survey

References (73)

1. American Thoracic Society/American Sleep Disorders Association. Statement on health outcomes research in sleep apnea. Am J Respir Crit Care Med 1998, 157: 335-341
2. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22: 667-689
3. st ed. Westchester, IL: American Academy of Sleep Medicine, 2007.
4. Guilleminault C, van den Hoed J, Mitler M. Clinical features and evaluation of obstructive sleep apnea. In Principles and Practice of Sleep Medicine. Kryger MH, Roth T, Dement WC eds. Philadelphia: WB Saunders Co. 1994, 667-677
5. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age and sleep apnea in men. I. Prevalence and severity. Am J Respir Crit Care Med 1998, 157: 144-148
6. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001, 163: 608-613
7. Kales A, Vela-Bueno A, Kales JD. Sleep disorders: sleep apnea and narcolepsy. Ann Intern Med 1987, 106: 434-443
8. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85: 1151-1158
9. Svatikova A, Wolk R, Garni AS, Pohanka M, Somers VK. Interactions between obstructive sleep apnea and the metabolic syndrome. Curr Diab Rep 2005, 5: 53-58 (Pubitemid 40277801)
10. Zamarron C, Garcìa Paz V, Riveiro A. Obstructive sleep apnea syndrome is a systemic disease. Current evidence. Eur J Intern Med 2008, 19: 390-398
11. Pillar G, Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care 2008, 31: S303-9.
12. Chesson AL Jr, Berry RB, Pack A; American Academy of Sleep Medicine; American Thoracic Society; American College of Chest Physicians. Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep 2003, 26: 907-913
13. Mattei A, Tabbia G, Baldi S. Diagnosis of sleep apnea. Minerva Med 2004, 95: 213-231
14. Collop NA, Anderson WM, Boehlecke B, et al; Portable Monitoring Task Force of the American Academy of Sleep Medicine. Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2007, 3: 737-747
15. Littner M. Polysomnography in the diagnosis of the obstructive sleep apnea-hypopnea syndrome: where do we draw the line? Chest 2000, 118: 286-288
16. Garni AS, Caples SM, Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 2003, 32: 869-894
17. Bloch KE. Alternatives to CPAP in the treatment of the obstructive sleep apnea syndrome. Swiss Med Wkly 2006, 136: 261-267 (Pubitemid 43773916)
18. Phillips B. Upper airway surgery does not have a major role in the treatment of sleep apnea. J Clin Sleep Med 2005, 1: 241-245
19. Powell NB. Contemporary surgery for obstructive sleep apnea syndrome. Clin Exp Otorhinolaryngol 2009, 2: 107-114
20. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004, 292: 1724-1737 (Pubitemid 39346675)
21. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. Serun levels of insulin like growth factor I (IGF-I) and IGF binding protein 3 reflects spontaneous growth hormone secretion. J Clin Endocrinol Metab 1993, 76: 1610-1616
22. Bernstein D, Kasper JR, Rosenfeld RG, Hintz RL. Decreased serum insulin like growth factor-I associated with growth failure in newborn lambs with experimental cyanotic heart disease. J Clin Invest 1992, 89: 1128-1132
23. Xu NY, Chen XQ, Du JZ, Wang TY, Duan C. Intermittent hypoxia causes a suppressed pituitary growth hormone through somatostatin. Neuro Endocrinol Lett 2004, 25: 361-367 (Pubitemid 39619302)
24. Zhang YS, Du JZ. The response of growth hormone and prolactin of rats to hypoxia. Neurosci Lett 2000, 279: 137-140 (Pubitemid 30069812)
25. Polo O, Berthon-Jones M, Douglas NJ, Sullivan CE. Management of obstructive sleep apnoea/hypopnoea syndrome. Lancet 1994, 344: 656-660 (Pubitemid 24274313)
26. Ekstedt M, Akerstedt T, Söderström M. Microarousals during sleep are associated with increased levels of lipids, cortisol, and blood pressure. Psychosom Med 2004, 66: 925-931 (Pubitemid 39555544)
27. Semple PD, Beastall GH, Watson WS, Hume R. Hypothalamic-pituitary dysfunction in respiratory hypoxia. Thorax 1981, 36: 605-609 (Pubitemid 11054548)
28. Pastuszko A, Wilson DF, Ericinsk M. Neurotransmitter metabolism in rat brain synaptosomes: effect of anoxia and pH. J Neurochem 1982, 38: 1657-1667 (Pubitemid 12030319)
29. Raff H, Shinsako J, Keil LC, Dallman MF. Vasopressin, ACTH, and corticosteroids during hypercapnia and graded hypoxia in dogs. Am J Physiol 1983, 244: E453-8.
30. Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 2005, 99: 1592-1599 (Pubitemid 43014371)
31. Horner RL, Mohiaddin RH, Lowell DG. Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnea and weight matched controls. Eur Respir J 1989, 2: 613-622
32. Rubinstein I, Hoffstein V, Bradley TD. Lung volume-related changes in the pharyngeal area of obese females with and without obstructive sleep apnoea. Eur Respir J 1989, 2: 344-351 (Pubitemid 19146041)
33. Strobel RJ, Rosen RC. Obesity and weight loss in obstructive sleep apnoea: a critical review. Sleep 1996, 19: 104-115
34. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000, 320: 479-482 (Pubitemid 30173118)
35. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000, 342: 1378-1384 (Pubitemid 30262394)
36. Glass AR, Burman KD, Dahms WT, Boehm TM. Endocrine function in human obesity. Metabolism 1981, 130: 89-104.
37. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearances subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 1991, 72: 51-59 (Pubitemid 21921655)
38. Scacchi M, Pincelli AI, Cavagnini F. Growth hormone in obesity. Int J Obes Relat Metab Disord 1999, 23: 260-271
39. Maccario M, Valetto MR, Savio P, et al. Maximal secretory capacity of somatotrope cells in obesity: comparison with GH deficiency. Int J Obes Relat Metab Disord 1997, 21: 27-32. (Pubitemid 27037816)
40. Cordido F, Casanueva FF, Dieguez C. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity. J Clin Endocrinol Metab 1989, 68: 290-293 (Pubitemid 19052866)
41. Maccario M, Grottoli S, Procopio M, et al. The GH/IGF-I axis in obesity: influence of neuroendocrine and metabolic factors. Int J Obes Relat Metab Disord 2000, 24 (Suppl 2): S96-9. (Pubitemid 30461959)
42. Alvarez CV, Mallo F, Burguera B, Cacicedo L, Dieguez C, Casanueva FF. Evidence for a direct pituitary inhibition by free fatty acid of in vivo growth hormone responses to growth hormone-releasing hormone in the rat. Neuroendocrinology 1991, 53: 185-189
43. Frystyk J, Vestbo E, Skjaerbaek C, Mogensen CE, Orskov H. Free insulin-like growth factor in human obesity. Metabolism 1995, 44 (Suppl 4): 37-44.
44. Cordido F, Fernandez T, Martinez T, et al. Effect of acute pharmacological reduction of plasma free fatty acids on GHRH-induced GH secretion in obese adults with and without hypopituitarism. J Clin Endocrinol Metab 1998, 83: 4350-4354 (Pubitemid 29100134)
45. Cordido F, Alvarez-Castro P, Isidro ML, Casanueva FF, Dieguez C. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox, and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. Eur J Endocrinol 2003, 149: 117-122 (Pubitemid 36987153)
46. Maccario M, Tassone F, Grottoli S, Rossetto R, Gauna C, Ghigo E. Neuroendocrine and metabolic determinants of the adaptation of GH/IGF-I axis to obesity. Ann Endocrinol (Paris) 2002, 63: 140-144 (Pubitemid 34538260)
47. Alvarez-Castro P, Isidro ML, Garcia-Buela J, et al. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol (Oxf) 2004, 61: 250-255 (Pubitemid 39093122)
48. Maccario M, Ramunni J, Oleandri SE, et al. Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes Relat Metab Disord 1999, 23: 612-618 (Pubitemid 29276810)
49. Maccario M, Tassone F, Gauna C, et al. Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol 2001, 144: 251-256 (Pubitemid 32266294)
50. Mekala KC, Tritos NA. Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis. J Clin Endocrinol Metab 2009, 94: 130-137
51. Saini J, Krieger J, Brandenberger G, Wittersheim G, Follenius M. Continuous positive airway pressure treatment effects on growth hormone, insulin, and glucose profiles in obstructive sleep apnea patients. Horm Metab Res 1993, 25: 375-381 (Pubitemid 23208107)
52. Cooper BG, White JE, Ashworth LA, Alberti KG, Gibson GJ. Hormonal and metabolic profiles in subjects with obstructive sleep apnea syndrome and the acute effects of nasal continuous positive airway pressure (CPAP) treatment. Sleep 1995, 18: 172-179
53. Grunstein RR, Handelsman DJ, Lawrence SJ, Blackwell C, Caterson ID, Sullivan CE. Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy. J Clin Endocrinol Metab 1989, 68: 352-358 (Pubitemid 19052876)
54. Ursavas A, Karadag M, Ilcol YO, et al. Low level of IGF-1 in obesity may be related to obstructive sleep apnea syndrome. Lung 2007, 185: 309-314 (Pubitemid 47397492)
55. McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 2007, 175: 190-195 (Pubitemid 46115091)
56. Gianotti L, Pivetti S, Lanfranco F, et al. Concomitant impairment of growth hormone secretion and peripheral sensitivity in obese patients with obstructive sleep apnea syndrome. J Clin Endocrinol Metab 2002, 87: 5052-5057 (Pubitemid 35316345)
57. Ghigo E, Aimaretti G, Arvat E, Camanni F. Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocrine 2001, 15: 29-38. (Pubitemid 32802628)
58. Van Cauter E, Latta F, Nedeltcheva A. Reciprocal interactions between the GH axis and sleep. Growth Horm IGF Res 2004, 14 (Suppl A): S10-7. (Pubitemid 38701822)
59. Parker DC, Sassin JF, Mace JW, Gotlin RW, Rossman LG. Human growth hormone release during sleep: electroencephalographic correlation. J Clin Endocrinol Metab 1969, 29: 871-874
60. Ocampo-Lim B, Guo W, DeMott Friberg R, Barkan AL, Jaffe CA. Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist. J Clin Endocrinol Metab 1996, 81: 4396-4399 (Pubitemid 26412050)
61. Kerkhofs M, Van Cauter E, Van Onderbergen A, Caufriez A, Thomer MO, Copinschi G. Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am J Physiol 1993, 264: E594-8. (Pubitemid 23118172)
62. Kamel NS, Gammack JK. Insomnia in the elderly: cause, approach, and treatment. Am J Med 2006, 119: 463-469
63. Bradley TD, Phillipson EA. Pathogenesis and pathophysiology of obstructive sleep apnea syndrome. Med Clin N Am 1985, 69: 1169-1185 (Pubitemid 16199954)
64. Krieger J. Sleep apnea syndrome in adults. Bull Eur Physiopathol Respir 1986, 22: 147-189
65. Melmed S. Insulin suppresses growth hormone secretion by rat pituitary cells. J Clin Invest 1984, 73: 1425-1433 (Pubitemid 14139539)
66. Houston B, O'Neill IE. Insulin and growth hormone act synergistically to stimulate insulin-like growth factor-I production by cultured chicken hepatocytes. J Endocrinol 1991, 128: 389-393
67. Tassone F, Lanfranco F, Gianotti L, et al. Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol 2003, 59: 374-379 (Pubitemid 37046992)
68. Tasali E, Van Cauter E, Ehrmann DA. Polycystic ovary syndrome and obstructive sleep apnea. Sleep Med Clin 2008, 3: 37-46. (Pubitemid 351272411)
69. Tucci M, Nygard K, Tanswell BV, Farber HW, Hill DJ, Han VK. Modulation of insulin-like growth factor (IGF) and IGF binding protein biosynthesis by hypoxia in cultured vascular endothelial cells. Endocrinology 1998, 157: 13-24.
70. Broglio F, Fubini A, Morello M, et al. Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clin Endocrinol (Oxf) 1999, 50: 417-430 (Pubitemid 29193224)
71. Lindberg E, Berne C, Elmasry A, Hedner J, Janson C. CPAP treatment of a population-based sample - what are the benefits and the treatment compliance? Sleep Med 2006, 7: 553-560
72. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of insulin-like growth factor-1 and development of glucose intolerance: a prospective observational study. Lancet 2002, 359: 1740-1745
73. Laughlin GA, Barrett Connor E, Criqui MH, Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-I binding protein-1 levels with all-cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Clin Endocrinol Metab 2004, 89: 114-120 (Pubitemid 38183869)